Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Kallás EG[au]:

Search results

Items: 1 to 50 of 199

1.

Short Communication: Dried Blood Spots Stored at Room Temperature Should Not Be Used for HIV Incidence Testing.

Eisenberg AL, Patel EU, Packman ZR, Fernandez RE, Piwowar-Manning E, Hamilton EL, MacPhail C, Hughes J, Pettifor A, Kallas EG, Busch MP, Murphy G, Quinn TC, Eshleman SH, Laeyendecker O; for HPTN 068 and CEPHIA.

AIDS Res Hum Retroviruses. 2018 Dec;34(12):1013-1016. doi: 10.1089/AID.2018.0138. Epub 2018 Oct 17.

PMID:
30215267
2.

HLA-C downregulation by HIV-1 adapts to host HLA genotype.

Bachtel ND, Umviligihozo G, Pickering S, Mota TM, Liang H, Del Prete GQ, Chatterjee P, Lee GQ, Thomas R, Brockman MA, Neil S, Carrington M, Bwana B, Bangsberg DR, Martin JN, Kallas EG, Donini CS, Cerqueira NB, O'Doherty UT, Hahn BH, Jones RB, Brumme ZL, Nixon DF, Apps R.

PLoS Pathog. 2018 Sep 4;14(9):e1007257. doi: 10.1371/journal.ppat.1007257. eCollection 2018 Sep.

3.

Untold stories of the Zika virus epidemic in Brazil.

Avelino-Silva VI, Kallas EG.

Rev Med Virol. 2018 Nov;28(6):e2000. doi: 10.1002/rmv.2000. Epub 2018 Aug 3. Review.

PMID:
30074287
4.

Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells.

Paquin-Proulx D, Costa PR, Terrassani Silveira CG, Marmorato MP, Cerqueira NB, Sutton MS, O'Connor SL, Carvalho KI, Nixon DF, Kallas EG.

Front Immunol. 2018 Jun 19;9:1394. doi: 10.3389/fimmu.2018.01394. eCollection 2018.

5.

Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation.

Leal FE, Menezes SM, Costa EAS, Brailey PM, Gama L, Segurado AC, Kallas EG, Nixon DF, Dierckx T, Khouri R, Vercauteren J, Galvão-Castro B, Saraiva Raposo RA, Van Weyenbergh J.

Front Microbiol. 2018 May 22;9:985. doi: 10.3389/fmicb.2018.00985. eCollection 2018.

6.

Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques.

Magnani DM, Rogers TF, Maness NJ, Grubaugh ND, Beutler N, Bailey VK, Gonzalez-Nieto L, Gutman MJ, Pedreño-Lopez N, Kwal JM, Ricciardi MJ, Myers TA, Julander JG, Bohm RP, Gilbert MH, Schiro F, Aye PP, Blair RV, Martins MA, Falkenstein KP, Kaur A, Curry CL, Kallas EG, Desrosiers RC, Goldschmidt-Clermont PJ, Whitehead SS, Andersen KG, Bonaldo MC, Lackner AA, Panganiban AT, Burton DR, Watkins DI.

Nat Commun. 2018 Apr 24;9(1):1624. doi: 10.1038/s41467-018-04056-4.

7.

Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.

Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, Leite IC, Freitas L, Martins LMS, Torres TS, Vasconcelos R, De Boni RB, Anderson PL, Liu A, Luz PM, Veloso VG; PrEP Brasil Study Team.

Lancet HIV. 2018 Mar;5(3):e136-e145. doi: 10.1016/S2352-3018(18)30008-0. Epub 2018 Feb 18.

PMID:
29467098
8.

Syndemics among individuals enrolled in the PrEP Brasil Study.

De Boni RB, Machado IK, De Vasconcellos MTL, Hoagland B, Kallas EG, Madruga JV, Fernandes NM, Cerqueira NB, Moreira RI, Goulart SP, Veloso VG, Grinsztejn B, Luz PM.

Drug Alcohol Depend. 2018 Apr 1;185:168-172. doi: 10.1016/j.drugalcdep.2017.12.016. Epub 2018 Feb 10.

PMID:
29454927
9.

MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection.

Paquin-Proulx D, Avelino-Silva VI, Santos BAN, Silveira Barsotti N, Siroma F, Fernandes Ramos J, Coracini Tonacio A, Song A, Maestri A, Barros Cerqueira N, Felix AC, Levi JE, Greenspun BC, de Mulder Rougvie M, Rosenberg MG, Nixon DF, Kallas EG.

PLoS Negl Trop Dis. 2018 Jan 22;12(1):e0006154. doi: 10.1371/journal.pntd.0006154. eCollection 2018 Jan.

10.

Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL.

Ricciardi MJ, Magnani DM, Grifoni A, Kwon YC, Gutman MJ, Grubaugh ND, Gangavarapu K, Sharkey M, Silveira CGT, Bailey VK, Pedreño-Lopez N, Gonzalez-Nieto L, Maxwell HS, Domingues A, Martins MA, Pham J, Weiskopf D, Altman J, Kallas EG, Andersen KG, Stevenson M, Lichtenberger P, Choe H, Whitehead SS, Sette A, Watkins DI.

PLoS Negl Trop Dis. 2017 Dec 21;11(12):e0006000. doi: 10.1371/journal.pntd.0006000. eCollection 2017 Dec.

11.

Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas.

Grifoni A, Angelo MA, Lopez B, O'Rourke PH, Sidney J, Cerpas C, Balmaseda A, Silveira CGT, Maestri A, Costa PR, Durbin AP, Diehl SA, Phillips E, Mallal S, De Silva AD, Nchinda G, Nkenfou C, Collins MH, de Silva AM, Lim MQ, Macary PA, Tatullo F, Solomon T, Satchidanandam V, Desai A, Ravi V, Coloma J, Turtle L, Rivino L, Kallas EG, Peters B, Harris E, Sette A, Weiskopf D.

Front Immunol. 2017 Oct 13;8:1309. doi: 10.3389/fimmu.2017.01309. eCollection 2017.

12.

Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques.

Magnani DM, Rogers TF, Beutler N, Ricciardi MJ, Bailey VK, Gonzalez-Nieto L, Briney B, Sok D, Le K, Strubel A, Gutman MJ, Pedreño-Lopez N, Grubaugh ND, Silveira CGT, Maxwell HS, Domingues A, Martins MA, Lee DE, Okwuazi EE, Jean S, Strobert EA, Chahroudi A, Silvestri G, Vanderford TH, Kallas EG, Desrosiers RC, Bonaldo MC, Whitehead SS, Burton DR, Watkins DI.

Sci Transl Med. 2017 Oct 4;9(410). pii: eaan8184. doi: 10.1126/scitranslmed.aan8184.

13.

Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans.

Grifoni A, Pham J, Sidney J, O'Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, Damasco PV, Phillips E, Mallal S, de Silva AM, Collins M, Durbin A, Diehl SA, Cerpas C, Balmaseda A, Kuan G, Coloma J, Harris E, Crowe JE Jr, Stone M, Norris PJ, Busch M, Vivanco-Cid H, Cox J, Graham BS, Ledgerwood JE, Turtle L, Solomon T, Kallas EG, Watkins DI, Weiskopf D, Sette A.

J Virol. 2017 Oct 4. pii: JVI.01469-17. doi: 10.1128/JVI.01469-17. [Epub ahead of print]

14.

Early and late pulmonary effects of nebulized LPS in mice: An acute lung injury model.

de Souza Xavier Costa N, Ribeiro Júnior G, Dos Santos Alemany AA, Belotti L, Zati DH, Frota Cavalcante M, Matera Veras M, Ribeiro S, Kallás EG, Nascimento Saldiva PH, Dolhnikoff M, Ferraz da Silva LF.

PLoS One. 2017 Sep 27;12(9):e0185474. doi: 10.1371/journal.pone.0185474. eCollection 2017.

15.

Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.

Grebe E, Welte A, Hall J, Keating SM, Facente SN, Marson K, Martin JN, Little SJ, Price MA, Kallas EG, Busch MP, Pilcher CD, Murphy G.

J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):547-555. doi: 10.1097/QAI.0000000000001537.

PMID:
28914669
16.

Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.

Magnani DM, Silveira CGT, Ricciardi MJ, Gonzalez-Nieto L, Pedreño-Lopez N, Bailey VK, Gutman MJ, Maxwell HS, Domingues A, Costa PR, Ferrari L, Goulart R, Martins MA, Martinez-Navio JM, Fuchs SP, Kalil J, Timenetsky MDC, Wrammert J, Whitehead SS, Burton DR, Desrosiers RC, Kallas EG, Watkins DI.

J Virol. 2017 Oct 27;91(22). pii: e00867-17. doi: 10.1128/JVI.00867-17. Print 2017 Nov 15.

17.

T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus.

Paquin-Proulx D, Leal FE, Terrassani Silveira CG, Maestri A, Brockmeyer C, Kitchen SM, Cabido VD, Kallas EG, Nixon DF.

Pathog Immun. 2017;2(2):274-292. doi: 10.20411/pai.v2i2.188. Epub 2017 Jun 30.

18.

Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys.

Magnani DM, Ricciardi MJ, Bailey VK, Gutman MJ, Pedreño-Lopez N, Silveira CGT, Maxwell HS, Domingues A, Gonzalez-Nieto L, Su Q, Newman RM, Pack M, Martins MA, Martinez-Navio JM, Fuchs SP, Rakasz EG, Allen TM, Whitehead SS, Burton DR, Gao G, Desrosiers RC, Kallas EG, Watkins DI.

Mol Ther. 2017 Oct 4;25(10):2323-2331. doi: 10.1016/j.ymthe.2017.06.020. Epub 2017 Jul 24.

19.

Asymptomatic anorectal Chlamydia trachomatis and Neisseria gonorrhoeae infections are associated with systemic CD8+ T-cell activation.

Vieira VA, Avelino-Silva VI, Cerqueira NB, Costa DA, Costa PR, Vasconcelos RP, Madruga VR, Moreira RI, Hoagland B, Veloso VG, Grinsztejn B, Kallás EG; PrEP Brasil Study Team.

AIDS. 2017 Sep 24;31(15):2069-2076. doi: 10.1097/QAD.0000000000001580.

PMID:
28692536
20.

Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.

Arif MS, Hunter J, Léda AR, Zukurov JPL, Samer S, Camargo M, Galinskas J, Kallás EG, Komninakis SV, Janini LM, Sucupira MC, Diaz RS.

J Virol. 2017 Sep 12;91(19). pii: e00793-17. doi: 10.1128/JVI.00793-17. Print 2017 Oct 1.

21.

A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus.

Magnani DM, Silveira CGT, Rosen BC, Ricciardi MJ, Pedreño-Lopez N, Gutman MJ, Bailey VK, Maxwell HS, Domingues A, Gonzalez-Nieto L, Avelino-Silva VI, Trindade M, Nogueira J, Oliveira CS, Maestri A, Felix AC, Levi JE, Nogueira ML, Martins MA, Martinez-Navio JM, Fuchs SP, Whitehead SS, Burton DR, Desrosiers RC, Kallas EG, Watkins DI.

PLoS Negl Trop Dis. 2017 Jun 12;11(6):e0005655. doi: 10.1371/journal.pntd.0005655. eCollection 2017 Jun.

22.

Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.

Aliota MT, Bassit L, Bradrick SS, Cox B, Garcia-Blanco MA, Gavegnano C, Friedrich TC, Golos TG, Griffin DE, Haddow AD, Kallas EG, Kitron U, Lecuit M, Magnani DM, Marrs C, Mercer N, McSweegan E, Ng LFP, O'Connor DH, Osorio JE, Ribeiro GS, Ricciardi M, Rossi SL, Saade G, Schinazi RF, Schott-Lerner GO, Shan C, Shi PY, Watkins DI, Vasilakis N, Weaver SC.

Antiviral Res. 2017 Aug;144:223-246. doi: 10.1016/j.antiviral.2017.06.001. Epub 2017 Jun 6. Review.

23.

Conserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.

Tarosso LF, Vieira VA, Sauer MM, Tomiyama HI, Kalil J, Kallas EG.

AIDS Res Hum Retroviruses. 2017 Aug;33(8):832-842. doi: 10.1089/AID.2016.0168. Epub 2017 Aug 3.

24.

Correction: p16INK4a Expression and Immunologic Aging in Chronic HIV Infection.

Ribeiro SP, Milush JM, Cunha-Neto E, Kallas EG, Kalil J, Passero LFD, Hunt PW, Deeks SG, Nixon DF, SenGupta D.

PLoS One. 2017 Apr 20;12(4):e0176509. doi: 10.1371/journal.pone.0176509. eCollection 2017.

25.

High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.

Hoagland B, Moreira RI, De Boni RB, Kallas EG, Madruga JV, Vasconcelos R, Goulart S, Torres TS, Marins LMS, Anderson PL, Luz PM, Costa Leite ID, Liu AY, Veloso VG, Grinsztejn B; PrEP Brasil Study TeamClinical Trial Number 01989611.

J Int AIDS Soc. 2017 Apr 6;20(1):21472. doi: 10.7448/IAS.20.1.21472.

26.

International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status.

Truong HM, Mehrotra M, Montoya O, Lama JR, Guanira JV, Casapía M, Veloso VG, Buchbinder SP, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Grant RM.

Sex Transm Dis. 2017 May;44(5):306-309. doi: 10.1097/OLQ.0000000000000601.

27.

MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.

Paquin-Proulx D, Greenspun BC, Costa EA, Segurado AC, Kallas EG, Nixon DF, Leal FE.

PLoS One. 2017 Apr 6;12(4):e0175345. doi: 10.1371/journal.pone.0175345. eCollection 2017.

28.

Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults.

Miyaji KT, Avelino-Silva VI, Simões M, Freire MD, Medeiros CR, Braga PE, Neves MA, Lopes MH, Kallas EG, Sartori AM.

Rev Inst Med Trop Sao Paulo. 2017 Apr 3;59:e2. doi: 10.1590/S1678-9946201759002.

29.

Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.

Schlusser KE, Pilcher C, Kallas EG, Santos BR, Deeks SG, Facente S, Keating SM, Busch MP, Murphy G, Welte A, Quinn T, Eshleman SH, Laeyendecker O.

PLoS One. 2017 Feb 23;12(2):e0172283. doi: 10.1371/journal.pone.0172283. eCollection 2017.

30.

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.

Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators.

N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.

31.

Thromboelastometry analysis of thrombocytopenic dengue patients: a cross-sectional study.

Piza FM, Corrêa TD, Marra AR, Guerra JC, Rodrigues RD, Villarinho AA, de Aranda VF, Shiramizo SC, de Lima MR, Kallas EG, Cavalcanti AB.

BMC Infect Dis. 2017 Jan 19;17(1):89. doi: 10.1186/s12879-017-2204-4.

32.

CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients.

Avelino-Silva VI, Miyaji KT, Hunt PW, Huang Y, Simoes M, Lima SB, Freire MS, Caiaffa-Filho HH, Hong MA, Costa DA, Dias JZ, Cerqueira NB, Nishiya AS, Sabino EC, Sartori AM, Kallas EG.

PLoS Negl Trop Dis. 2016 Dec 12;10(12):e0005219. doi: 10.1371/journal.pntd.0005219. eCollection 2016 Dec.

33.

p16INK4a Expression and Immunologic Aging in Chronic HIV Infection.

Ribeiro SP, Milush JM, Cunha-Neto E, Kallas EG, Kalil J, Passero LFD, Hunt PW, Deeks SG, Nixon DF, SenGupta D.

PLoS One. 2016 Nov 18;11(11):e0166759. doi: 10.1371/journal.pone.0166759. eCollection 2016. Erratum in: PLoS One. 2017 Apr 20;12 (4):e0176509.

34.

Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil.

Hoagland B, De Boni RB, Moreira RI, Madruga JV, Kallas EG, Goulart SP, Cerqueira N, Torres TS, Luz PM, Fernandes NM, Liu AY, Grinsztejn B, Veloso VG; PrEP Brasil Study Team.

AIDS Behav. 2017 May;21(5):1278-1287. doi: 10.1007/s10461-016-1516-5.

PMID:
27531461
35.

Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.

Keating SM, Kassanjee R, Lebedeva M, Facente SN, MacArthur JC, Grebe E, Murphy G, Welte A, Martin JN, Little S, Price MA, Kallas EG, Busch MP, Pilcher CD.

J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):581-588.

36.

Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion.

Paquin-Proulx D, Barsotti NS, Santos BA, Marinho AK, Kokron CM, Carvalho KI, Barros MT, Kalil J, Nixon DF, Kallas EG.

Medicine (Baltimore). 2016 Jul;95(30):e4304. doi: 10.1097/MD.0000000000004304.

37.

Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.

Kassanjee R, Pilcher CD, Busch MP, Murphy G, Facente SN, Keating SM, Mckinney E, Marson K, Price MA, Martin JN, Little SJ, Hecht FM, Kallas EG, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA).

AIDS. 2016 Sep 24;30(15):2361-71. doi: 10.1097/QAD.0000000000001209.

38.

Forging Collaborative Relationships in Brazil: From AIDS to ZIKV.

O'Connor DH, Osorio JE, Tanuri A, Kallas EG.

Cell. 2016 Jun 30;166(1):2-4. doi: 10.1016/j.cell.2016.06.023.

39.

Surface expression of inhibitory (CTLA-4) and stimulatory (OX40) receptors by CD4+ regulatory T cell subsets circulating in human malaria.

Gonçalves-Lopes RM, Lima NF, Carvalho KI, Scopel KK, Kallás EG, Ferreira MU.

Microbes Infect. 2016 Oct;18(10):639-648. doi: 10.1016/j.micinf.2016.06.003. Epub 2016 Jun 16.

40.

Th17 cells and CD4(+) multifunctional T cells in patients with systemic lupus erythematosus.

Araújo JA, Mesquita D Jr, de Melo Cruvinel W, Salmazi KI, Kallás EG, Andrade LE.

Rev Bras Reumatol Engl Ed. 2016 Jan-Feb;56(1):28-36. doi: 10.1016/j.rbre.2015.10.003. Epub 2015 Nov 19. English, Portuguese.

41.

Real-Time Sharing of Zika Virus Data in an Interconnected World.

Kallas EG, O'Connor DH.

JAMA Pediatr. 2016 Jul 1;170(7):633-4. doi: 10.1001/jamapediatrics.2016.0857. No abstract available.

PMID:
27031608
42.

Increase in cholinergic modulation with pyridostigmine induces anti-inflammatory cell recruitment soon after acute myocardial infarction in rats.

Rocha JA, Ribeiro SP, França CM, Coelho O, Alves G, Lacchini S, Kallás EG, Irigoyen MC, Consolim-Colombo FM.

Am J Physiol Regul Integr Comp Physiol. 2016 Apr 15;310(8):R697-706. doi: 10.1152/ajpregu.00328.2015. Epub 2016 Jan 20.

43.

The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis.

Yamamoto ES, Campos BL, Jesus JA, Laurenti MD, Ribeiro SP, Kallás EG, Rafael-Fernandes M, Santos-Gomes G, Silva MS, Sessa DP, Lago JH, Levy D, Passero LF.

PLoS One. 2015 Dec 16;10(12):e0144946. doi: 10.1371/journal.pone.0144946. eCollection 2015.

44.

Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial.

Kuebler PJ, Shaw BI, Leadabrand KS, Mehrotra ML, Grant RM, Kallás EG, Nixon DF.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):184-8. doi: 10.1097/QAI.0000000000000923.

45.

Persistence of Yellow Fever vaccine-induced antibodies after cord blood stem cell transplant.

Avelino-Silva VI, Freire Mda S, Rocha V, Rodrigues CA, Novis YS, Sabino EC, Kallas EG.

Hum Vaccin Immunother. 2016 Apr 2;12(4):937-8. doi: 10.1080/21645515.2015.1112475. Epub 2015 Nov 30.

46.

HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.

Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM; iPrEx investigators.

Lancet HIV. 2015 Dec;2(12):e512-9. doi: 10.1016/S2352-3018(15)00206-4. Epub 2015 Nov 6.

47.

Efficient Identification of HIV Serodiscordant Couples by Existing HIV Testing Programs in South Brazil.

Pilcher CD, Bisol CA, Paganella MP, Vallabhaneni S, da Motta LR, Kato SK, Sperhacke RD, Kallas EG, Hecht FM, Diaz RS.

PLoS One. 2015 Nov 12;10(11):e0142638. doi: 10.1371/journal.pone.0142638. eCollection 2015.

48.

Abnormal phenotypic distribution of regulatory and effector T cells in octogenarian and nonagenarian women.

Cruvinel Wde M, Mesquita Júnior D, Araújo JA, Samazi KC, Kállas EG, Cendoroglo MS, Andrade LE.

Rev Assoc Med Bras (1992). 2015 Aug;61(4):329-35. doi: 10.1590/1806-9282.61.04.329.

49.

Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection.

Bailey AL, Lauck M, Mohns M, Peterson EJ, Beheler K, Brunner KG, Crosno K, Mejia A, Mutschler J, Gehrke M, Greene J, Ericsen AJ, Weiler A, Lehrer-Brey G, Friedrich TC, Sibley SD, Kallas EG, Capuano S 3rd, Rogers J, Goldberg TL, Simmons HA, O'Connor DH.

Sci Transl Med. 2015 Sep 16;7(305):305ra144. doi: 10.1126/scitranslmed.aab3467.

50.

CD4/CD8 Ratio Predicts Yellow Fever Vaccine-Induced Antibody Titers in Virologically Suppressed HIV-Infected Patients.

Avelino-Silva VI, Miyaji KT, Mathias A, Costa DA, de Carvalho Dias JZ, Lima SB, Simoes M, Freire MS, Caiaffa-Filho HH, Hong MA, Lopes MH, Sartori AM, Kallas EG.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):189-95. doi: 10.1097/QAI.0000000000000845.

PMID:
26361176

Supplemental Content

Loading ...
Support Center